ADAP - Adaptimmune EPS beats by $0.20 misses on revenue August, 06 2020 07:34 AM Adaptimmune Therapeutics plc Adaptimmune (NASDAQ:ADAP): Q2 GAAP EPS of -$0.04 beats by $0.20.More news on: Adaptimmune Therapeutics plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...